SAPHNELO Data: Remission Is An Achievable Goal

November 9, 2023 – SAPHNELO data shows patients are more likely to achieve and sustain remission in systemic lupus erythematosus compared to standard therapy alone.

For more information, please visit https://www.astrazeneca-us.com/media/press-releases/2023/saphnelo-data-show-patients-are-more-likely-to-achieve-and-sustain-remission-in-systemic-lupus-erythematosus-compared-to-standard-therapy-alone.html

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Anifrolumab Now Covered Under BC PharmaCare for Lupus Treatment

Read

Belimumab for Lupus Nephritis in BC Now Approved Under BC Renal Formulary

Read

A Mother’s Lupus Story: Carolina and Luca’s Journey

Read